Why the study?
Certain hospital practices have become common but may offer little clinical value to patients.
Does universal venous thromboembolism chemoprophylaxis provide value in low-risk hospitalized medical patients?
Does universal venous thromboembolism chemoprophylaxis provide value in low-risk hospitalized medical patients?
This review questions the clinical value of universal venous thromboembolism chemoprophylaxis in low-risk hospitalized medical patients.
Answers are grounded in this paper and cite their sources.
Questions routine universal VTE prophylaxis in low-risk medical inpatients; hypothesis-generating and requires prospective trials before practice change.
Inspired by the ABIM Foundation's Choosing Wisely® campaign, the “Things We Do for No Reason™” (TWDFNR) series reviews practices that have become common parts of hospital care but may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent clear‐cut conclusions or clinical practice standards but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion.
No takes yet. Share an insight, caveat, or question.
Barlow et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: